Download ATRIAL FIBRILLATION - ATRIAL FLUTTER (A08)

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Cardiac contractility modulation wikipedia , lookup

Amiodarone wikipedia , lookup

Lutembacher's syndrome wikipedia , lookup

Cardiac surgery wikipedia , lookup

Management of acute coronary syndrome wikipedia , lookup

Myocardial infarction wikipedia , lookup

Arrhythmogenic right ventricular dysplasia wikipedia , lookup

Quantium Medical Cardiac Output wikipedia , lookup

Dextro-Transposition of the great arteries wikipedia , lookup

Ventricular fibrillation wikipedia , lookup

Electrocardiography wikipedia , lookup

Heart arrhythmia wikipedia , lookup

Atrial fibrillation wikipedia , lookup

Transcript
ADULT TREATMENT GUIDELINES
CARDIAC
ATRIAL FIBRILLATION - ATRIAL FLUTTER (A08)
Atrial Fibrillation: Rhythm is irregularly irregular. Atrial rate 350 to 600 but, as a rule,
cannot be counted. Ventricular rate is usually between 160 and 180, but may be much
slower if patient on medication such as digoxin, amiodarone, B-blockers, or Ca-channel
blockers. Fibrillatory waves may be coarse or fine. QRS complex usually normal.
Some patients may alternate between atrial fibrillation and atrial flutter.
Atrial Flutter: Atrial rhythm regular. Ventricular rhythm may be regular or irregular if
variable block is present. Ventricular rate 140 to 160, but may be slower if the patient is
on medication such as digoxin, amiodarone, B-blockers, or Ca-channel blockers. QRS
complex usually normal and may follow every second, third or fourth flutter wave. Some
patients may alternate between atrial fibrillation and atrial flutter.
ASSESSMENT
RESPIRATORY MONITORING - Apply and monitor Capnography and
Pulse Oximetry.
OXYGEN- As appropriate.
ECG MONITOR
VASCULAR ACCESS IV/IO, rate as indicated.
*12 LEAD ECG- If patient’s condition allows.
UNSTABLE, heart rate > 150 beats/minute with serious signs or
symptoms related to tachycardia.
MIDAZOLAM - 2 mg slow IV/IO/IN/IM. If the patient’s clinical condition
is critical, do not delay cardioversion and cardiovert without sedation.
CARDIOVERT – Synchronized at 50 J. If unsuccessful, increase by 50 J
to maximum 200 J on repeat cardioversion.
BORDERLINE, heart rate < 150 with serious signs and symptoms or >
150 without serious signs or symptoms.
OBSERVE
CALCIUM CHLORIDE - 500-1000 mg slow IV/IO push.
Use with caution in patients taking digoxin.
VERAPAMIL - 5 mg slow IV/IO push. May repeat in 15 minutes at 10
mg slow IV push.
F
X
E
X
P B D
X
X
X
X
X
X
X
X
X
X
X
X
F
E
P B D
X
X
F
E
P B D
X
X
X
* If 12 Lead ECG interprets an S-T Elevation Myocardial Infarction (STEMI), refer to
Policy 531.20 for patient destination.
Provider Key
F = First Responder
E = EMT
P = Paramedic
B = Base Hospital Order Required
D = Base Hospital Physician Order Required
EFFECTIVE: 11-01-2015
X
X